Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus Article Swipe
Yuichiro Ito
,
James Van Schyndle
,
Takuya Nishimura
,
Toshifumi Sugitani
,
Tomomi Kimura
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1007/s13300-019-00708-w
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1007/s13300-019-00708-w
Astellas Pharma Inc., Tokyo, Japan.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s13300-019-00708-w
- https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdf
- OA Status
- gold
- Cited By
- 7
- References
- 26
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2981287710
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2981287710Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s13300-019-00708-wDigital Object Identifier
- Title
-
Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes MellitusWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-10-15Full publication date if available
- Authors
-
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, Toshifumi Sugitani, Tomomi KimuraList of authors in order
- Landing page
-
https://doi.org/10.1007/s13300-019-00708-wPublisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdfDirect OA link when available
- Concepts
-
Medicine, Glycated hemoglobin, Diabetes mellitus, Body mass index, Internal medicine, Pharmacoepidemiology, Type 2 diabetes, Endocrinology, Pharmacology, Medical prescriptionTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
7Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2022: 1, 2021: 3, 2020: 2Per-year citation counts (last 5 years)
- References (count)
-
26Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2981287710 |
|---|---|
| doi | https://doi.org/10.1007/s13300-019-00708-w |
| ids.doi | https://doi.org/10.1007/s13300-019-00708-w |
| ids.mag | 2981287710 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31617152 |
| ids.openalex | https://openalex.org/W2981287710 |
| fwci | 1.26328083 |
| type | article |
| title | Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus |
| biblio.issue | 6 |
| biblio.volume | 10 |
| biblio.last_page | 2231 |
| biblio.first_page | 2219 |
| grants[0].funder | https://openalex.org/F4320323024 |
| grants[0].award_id | |
| grants[0].funder_display_name | Astellas Pharma |
| topics[0].id | https://openalex.org/T10401 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2712 |
| topics[0].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[0].display_name | Diabetes Treatment and Management |
| topics[1].id | https://openalex.org/T11339 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9947999715805054 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Metabolism, Diabetes, and Cancer |
| topics[2].id | https://openalex.org/T10560 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9871000051498413 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Diabetes Management and Research |
| funders[0].id | https://openalex.org/F4320307769 |
| funders[0].ror | https://ror.org/05pw69n24 |
| funders[0].display_name | Astellas Pharma US |
| funders[1].id | https://openalex.org/F4320323024 |
| funders[1].ror | https://ror.org/01cjash87 |
| funders[1].display_name | Astellas Pharma |
| funders[2].id | https://openalex.org/F4320324271 |
| funders[2].ror | https://ror.org/01cjash87 |
| funders[2].display_name | Astellas Foundation for Research on Metabolic Disorders |
| is_xpac | False |
| apc_list.value | 4300 |
| apc_list.currency | GBP |
| apc_list.value_usd | 6000 |
| apc_paid.value | 4300 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 6000 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8511253595352173 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777538456 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7125487327575684 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q311213 |
| concepts[1].display_name | Glycated hemoglobin |
| concepts[2].id | https://openalex.org/C555293320 |
| concepts[2].level | 2 |
| concepts[2].score | 0.650244951248169 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[2].display_name | Diabetes mellitus |
| concepts[3].id | https://openalex.org/C2780221984 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6184638738632202 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q131191 |
| concepts[3].display_name | Body mass index |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5699830651283264 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C23276603 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4582982659339905 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q158230 |
| concepts[5].display_name | Pharmacoepidemiology |
| concepts[6].id | https://openalex.org/C2777180221 |
| concepts[6].level | 3 |
| concepts[6].score | 0.3647163510322571 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[6].display_name | Type 2 diabetes |
| concepts[7].id | https://openalex.org/C134018914 |
| concepts[7].level | 1 |
| concepts[7].score | 0.22035259008407593 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[7].display_name | Endocrinology |
| concepts[8].id | https://openalex.org/C98274493 |
| concepts[8].level | 1 |
| concepts[8].score | 0.17729142308235168 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[8].display_name | Pharmacology |
| concepts[9].id | https://openalex.org/C2426938 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[9].display_name | Medical prescription |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8511253595352173 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/glycated-hemoglobin |
| keywords[1].score | 0.7125487327575684 |
| keywords[1].display_name | Glycated hemoglobin |
| keywords[2].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[2].score | 0.650244951248169 |
| keywords[2].display_name | Diabetes mellitus |
| keywords[3].id | https://openalex.org/keywords/body-mass-index |
| keywords[3].score | 0.6184638738632202 |
| keywords[3].display_name | Body mass index |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5699830651283264 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/pharmacoepidemiology |
| keywords[5].score | 0.4582982659339905 |
| keywords[5].display_name | Pharmacoepidemiology |
| keywords[6].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[6].score | 0.3647163510322571 |
| keywords[6].display_name | Type 2 diabetes |
| keywords[7].id | https://openalex.org/keywords/endocrinology |
| keywords[7].score | 0.22035259008407593 |
| keywords[7].display_name | Endocrinology |
| keywords[8].id | https://openalex.org/keywords/pharmacology |
| keywords[8].score | 0.17729142308235168 |
| keywords[8].display_name | Pharmacology |
| language | en |
| locations[0].id | doi:10.1007/s13300-019-00708-w |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S16535137 |
| locations[0].source.issn | 1869-6953, 1869-6961 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1869-6953 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Diabetes Therapy |
| locations[0].source.host_organization | https://openalex.org/P4310320330 |
| locations[0].source.host_organization_name | Adis, Springer Healthcare |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320330 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Diabetes Therapy |
| locations[0].landing_page_url | https://doi.org/10.1007/s13300-019-00708-w |
| locations[1].id | pmid:31617152 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Diabetes therapy : research, treatment and education of diabetes and related disorders |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31617152 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:6848551 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Diabetes Ther |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6848551 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5052078893 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3117-9328 |
| authorships[0].author.display_name | Yuichiro Ito |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I142395110 |
| authorships[0].affiliations[0].raw_affiliation_string | Astellas Pharma Inc., Tokyo, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I142395110 |
| authorships[0].institutions[0].ror | https://ror.org/01cjash87 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I142395110 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Astellas Pharma (Japan) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuichiro Ito |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Astellas Pharma Inc., Tokyo, Japan |
| authorships[1].author.id | https://openalex.org/A5032944069 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | James Van Schyndle |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210165171 |
| authorships[1].affiliations[0].raw_affiliation_string | Astellas US, LLC., Northbrook, IL, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210165171 |
| authorships[1].institutions[0].ror | https://ror.org/05pw69n24 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I142395110, https://openalex.org/I4210165171 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Astellas Pharma (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | James Van Schyndle |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Astellas US, LLC., Northbrook, IL, USA |
| authorships[2].author.id | https://openalex.org/A5101605491 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3136-0127 |
| authorships[2].author.display_name | Takuya Nishimura |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I142395110 |
| authorships[2].affiliations[0].raw_affiliation_string | Astellas Pharma Inc., Tokyo, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I142395110 |
| authorships[2].institutions[0].ror | https://ror.org/01cjash87 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I142395110 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Astellas Pharma (Japan) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Takuya Nishimura |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Astellas Pharma Inc., Tokyo, Japan |
| authorships[3].author.id | https://openalex.org/A5084620991 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9796-2809 |
| authorships[3].author.display_name | Toshifumi Sugitani |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I142395110 |
| authorships[3].affiliations[0].raw_affiliation_string | Astellas Pharma Inc., Tokyo, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I142395110 |
| authorships[3].institutions[0].ror | https://ror.org/01cjash87 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I142395110 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Astellas Pharma (Japan) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Toshifumi Sugitani |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Astellas Pharma Inc., Tokyo, Japan |
| authorships[4].author.id | https://openalex.org/A5075681252 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8594-3387 |
| authorships[4].author.display_name | Tomomi Kimura |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I142395110 |
| authorships[4].affiliations[0].raw_affiliation_string | Astellas Pharma Inc., Tokyo, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I142395110 |
| authorships[4].institutions[0].ror | https://ror.org/01cjash87 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I142395110 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Astellas Pharma (Japan) |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Tomomi Kimura |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Astellas Pharma Inc., Tokyo, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10401 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2712 |
| primary_topic.subfield.display_name | Endocrinology, Diabetes and Metabolism |
| primary_topic.display_name | Diabetes Treatment and Management |
| related_works | https://openalex.org/W4211005696, https://openalex.org/W1508735077, https://openalex.org/W2909998491, https://openalex.org/W4387645675, https://openalex.org/W4220739572, https://openalex.org/W2068959287, https://openalex.org/W4297794661, https://openalex.org/W2204990270, https://openalex.org/W4240813697, https://openalex.org/W2360827856 |
| cited_by_count | 7 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2021 |
| counts_by_year[2].cited_by_count | 3 |
| counts_by_year[3].year | 2020 |
| counts_by_year[3].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s13300-019-00708-w |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S16535137 |
| best_oa_location.source.issn | 1869-6953, 1869-6961 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1869-6953 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Diabetes Therapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320330 |
| best_oa_location.source.host_organization_name | Adis, Springer Healthcare |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320330 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Diabetes Therapy |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s13300-019-00708-w |
| primary_location.id | doi:10.1007/s13300-019-00708-w |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S16535137 |
| primary_location.source.issn | 1869-6953, 1869-6961 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1869-6953 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Diabetes Therapy |
| primary_location.source.host_organization | https://openalex.org/P4310320330 |
| primary_location.source.host_organization_name | Adis, Springer Healthcare |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320330 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s13300-019-00708-w.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Diabetes Therapy |
| primary_location.landing_page_url | https://doi.org/10.1007/s13300-019-00708-w |
| publication_date | 2019-10-15 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W4211190017, https://openalex.org/W2093133419, https://openalex.org/W2073246045, https://openalex.org/W1869287998, https://openalex.org/W2052997601, https://openalex.org/W2036498924, https://openalex.org/W2060263164, https://openalex.org/W2048875545, https://openalex.org/W1973273635, https://openalex.org/W2013707956, https://openalex.org/W1974115114, https://openalex.org/W2800723402, https://openalex.org/W2424539745, https://openalex.org/W2725025545, https://openalex.org/W2939222610, https://openalex.org/W2899764361, https://openalex.org/W2914817413, https://openalex.org/W2574115541, https://openalex.org/W2763987852, https://openalex.org/W2493381021, https://openalex.org/W2912901809, https://openalex.org/W4232249876, https://openalex.org/W2086197387, https://openalex.org/W2919521397, https://openalex.org/W1985941010, https://openalex.org/W2794676804 |
| referenced_works_count | 26 |
| abstract_inverted_index.Inc., | 2 |
| abstract_inverted_index.Japan. | 4 |
| abstract_inverted_index.Pharma | 1 |
| abstract_inverted_index.Tokyo, | 3 |
| abstract_inverted_index.Astellas | 0 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile.value | 0.77483796 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |